Insider Transactions in Q1 2024 at Caladrius Biosciences, Inc. (CLBS)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 11
2024
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,026
-0.58%
|
$2,052
$2.99 P/Share
|
|
Jan 10
2024
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,470
-1.94%
|
$10,410
$3.0 P/Share
|
|
Jan 10
2024
|
Kristen K Buck EVP, R&D and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
512
-0.94%
|
$1,536
$3.0 P/Share
|
|
Jan 09
2024
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
20,046
-5.16%
|
$60,138
$3.08 P/Share
|
|
Jan 09
2024
|
David J Mazzo President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
94,000
+32.05%
|
-
|
|
Jan 09
2024
|
Kristen K Buck EVP, R&D and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,368
-4.58%
|
$16,104
$3.08 P/Share
|
|
Jan 09
2024
|
Kristen K Buck EVP, R&D and CMO |
BUY
Grant, award, or other acquisition
|
Direct |
27,000
+31.06%
|
-
|
|
Jan 09
2024
|
Cynthia Schwalm Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,480
+28.36%
|
-
|
|
Jan 09
2024
|
Heidi Henson Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,480
+33.04%
|
-
|
|
Jan 09
2024
|
Steven M Klosk Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,480
+28.21%
|
-
|
|
Jan 09
2024
|
Mohammad Azab Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,480
+24.92%
|
-
|
|
Jan 09
2024
|
Gregory B Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,480
+28.28%
|
-
|